Ravi Salgia, M.D., Ph.D.
Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Chair in Medical Oncology at City of Hope's comprehensive cancer center. There, he leads over 100 medical oncology faculty as professor and chair of the Department of Medical Oncology & Therapeutics Research.
Prior to joining City of Hope, Dr. Salgia served as a tenured professor of medicine, pathology, and dermatology, director of the Thoracic Oncology Program and the Aerodigestive Tract Program Translational Research Lab in the section of hematology/oncology, vice chair for translational research in the Department of Medicine and associate director for translational science at the University of Chicago Comprehensive Cancer Center in Chicago. Prior to the University of Chicago, he was a faculty member at the Dana-Farber Institute and Harvard Medical School for a decade, initially as an instructor of medicine, then assistant professor of medicine.
Dr. Salgia earned his undergraduate summa cum laude in mathematics, biology and chemistry, and then his medical doctorate and Ph.D. from Loyola University in Chicago, where he also completed fellowships in neurochemistry and physiology. As an undergraduate and graduate student, he published several manuscripts in mathematics and basic sciences. He continued his postgraduate training with an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, followed by a fellowship in medical oncology at Dana-Farber Cancer Institute in Boston, during which time he also served as a clinical fellow at Harvard Medical School in Boston.
Board-certified in medical oncology, Dr. Salgia serves on various panels for the National Cancer Institute. He has consistently received research grants from the National Institutes of Health for his research work and has been awarded several invention discoveries and patents related to his work. He is the co-chief editor of the Journal of Carcinogenesis. Dr. Salgia also serves on the editorial advisory board of four additional journals. He has authored over 550 peer-reviewed articles, reviews, and editorials, three books, and over 30 book chapters.
Dr. Salgia is frequently invited to present his work at national and international conferences and symposia, and is the recipient of several honors and awards, including πμε National Competition in Mathematics, Richard V. Andree Award for “Volume of an n-Dimensional Unit Sphere," 2016 Asclepius Award from the Bonnie J. Addario Lung Cancer Foundation, IACA Award for Outstanding Contributions to Oncology, Sun Pharma Award and served as a member of NIH/NCI’s Tumor Progression and Metastasis Study Section, and CONC Study Section. He is currently on the board of directors for the National Comprehensive Cancer Network. He is part of the CI4CC "Directors Circle." He is on the local leadership board for American Lung Association. Also, he is recognized on “Best Doctors” and “Top Doctors” lists, and is listed in Wikipedia.
Duarte - Main Campus
Duarte, CA 91010
American Board of Internal Medicine, Medical Oncology
1987, M.D., Loyola University School of Medicine, Chicago, IL
1985, Ph.D., Loyola University School of Medicine, Chicago, IL
1981, B.A. in Chemistry, Summa Cum Laude, Loyola University, Chicago, IL
1981, B.S. in Mathematics and Biology, Summa Cum Laude, Loyola University, Chicago, IL
1990-1993, Fellow in Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
1990-1993, Clinical Fellow in Medicine, Harvard Medical School, Boston, MA
1990-1993, Clinical Fellow in Medicine, Brigham and Women's Hospital, Boston, MA
1988-1990, Internal Medicine Resident, The Johns Hopkins Hospital, Baltimore, MD
1987-1988, Intern, The Johns Hopkins Hospital, Baltimore, MD
2016-present, Arthur & Rosalie Kaplan Chair in Medical Oncology, Professor and Chair, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2016-2020, Associate Director for Clinical Sciences, City of Hope, Duarte, CA
2016-present, Professor of Medicine: Emeritus, University of Chicago, Chicago, IL
2008-2015, Professor of Medicine, Pathology and Dermatology, University of Chicago, Chicago, IL
2006-2010, Co-director, Physician Scientist Development Program, Department of Medicine, University of Chicago, Chicago, IL
2003-2008, Associate Professor of Medicine, Pathology and Dermatology, University of Chicago, Chicago, IL
1997-2003, Courtesy Staff Physician, Emerson Hospital, Concord, MA
1997-2003, Associate Physician, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
2003-2015, Co-director, Human Tissue Research Center for Thoracic Malignancies, Department of Pathology, University of Chicago, Chicago, IL
2003-2015, Chair, Upper Aerodigestive Group, University of Chicago Comprehensive Cancer Center, Chicago, IL
1994-1996, President and Chief Executive Officer, Foundation for Faces of Children, The Children's Hospital, Boston, MA
1993-1997, Board of Directors, Foundation for Faces of Children, The Children's Hospital, Boston, MA
1993-1996, Instructor in Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
1993-1996, Assistant Physician, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
He was the first to clone the focal adhesion protein paxillin and also localize the gene to 12q24. His laboratory also identified the gain-of-function mutations of paxillin in lung cancer, defined receptor tyrosine kinases and identified unique targets in lung cancer such as MET/RON, EGFR, ALK, ROS1, EPHA2 and EPHB4 receptor tyrosine kinases. Most recently, he and his group have identified unique mechanisms of resistance, and overcoming the resistance, in therapeutics against EGFR, ALK, MET and KRAS in lung cancer.
2023, Leaders of Influence: 2023, L.A.’s Top Doctor
2022, ALA Award (Champions Unite Award) – American Lung Association
2022, Excellence in Teaching Award, American Society of Clinical Oncology (ASCO)
2008-present, Top Doctors in America
2005-present, Best Doctors in America
2020, Los Angeles Business Journal, Top Doctor
2019, Sun Pharma Research Awards, Clinical Research
2017, Inducted as Maine South Distinguished Alumni (Alumni Wall of Honor), Park Ridge, IL
2017, IACA Award for Outstanding Contributions to Oncology
2012-2015, Chicago Magazine's Top Doctors
2013, Commencement Address, Oakton Community College
1992-1993, Frei Fellowship in Medical Oncology, Dana-Farber Cancer Institute
1990-1991, Dana-Farber Friends' Award in Oncology
1982, Richard V. Andee Award, National Competition in Mathematics
1981, Father Gerst Award in Mathematics, Loyola University
1977-1981, Dean's List, Loyola University
1977, Bausch and Lomb Award in Science, Loyola University1977, Language Award in Spanish, Loyola University
American Association for Advancement of Science
International Association for the Study of Lung Cancer
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology